Eli Lilly raises annual profit forecast on Zepbound sales
Eli Lilly has today raised its annual profit forecast and boosted its revenue expectations by $3 billion, as it benefited from ramped up manufacturing capacity for its highly popular weight-loss and diabetes drugs.
Business
• 08 Aug 24
